Product Connectivity Descriptors Boost Antiviral QSAR and QSPR Prediction

Molecular descriptors sit at the heart of quantitative structure–activity and structure–property relationships, the computational frameworks that chemists and bioinformaticians use to predict how a molecule will behave before it is ever synthesized or tested. Among the many families of two-dimensional descriptors, degree-based topological indices occupy a special place: they are computed directly from the molecular graph, where atoms become vertices and bonds become edges, and they require no quantum-chemical calculations, no three-dimensional conformer generation, and no expensive geometry optimization. Their interpretability and negligible computational cost have made them staples of virtual screening pipelines for decades. Yet a persistent weakness has limited their usefulness. Classical degree-based indices aggregate information across all edges of a molecule in an additive fashion, which means that in molecules containing highly connected substructures—dense clusters of atoms with many neighbors—the contribution of those dense regions can dominate the entire index, drowning out the signal carried by the rest of the molecular skeleton.

A new open-access study published in BMC Bioinformatics tackles this long-standing aggregation problem head-on. The research, authored by Mohammed Alsharafi, Azzam Altairi, Zaied Alhaj, and Yusuf Zeren, introduces and rigorously evaluates a fourteen-member family of product-connectivity descriptors, abbreviated PCI, designed to complement rather than replace the classical unweighted degree-based indices. The central idea is a product normalization applied to an existing degree kernel. Instead of summing edge contributions, the product formulation transforms how edge degrees combine, dampening the disproportionate influence of highly connected substructures and restoring sensitivity to the broader connectivity pattern of the molecule. The authors emphasize that the novelty lies not in proposing yet another fixed topological index, but in offering a general product-normalization scheme that can be grafted onto an existing degree kernel, making the approach modular and broadly applicable.

The theoretical half of the paper is devoted to establishing the mathematical credentials of the new family. The authors derive formal relations between each product-connectivity index and its corresponding unweighted classical counterpart, and they establish degree-extreme bounds—analytical limits that describe how the indices behave for graphs with extreme degree configurations. Such bounds matter in chemoinformatics because they guarantee that a descriptor is well-behaved across the full space of possible molecular graphs, not merely convenient on the handful of molecules in a training set. By proving these relationships, the team provides a principled foundation for the empirical work that follows, ensuring that the new descriptors are mathematically coherent and their behavior under degenerate conditions is understood in advance.

The empirical half of the study is unusually comprehensive by the standards of descriptor-evaluation papers. The authors assembled a curated dataset of 10,558 antiviral records drawn from ChEMBL, the public database of bioactivity data for drug-like molecules, covering 10,486 unique compounds. This scale is significant: many descriptor studies are validated on datasets of a few hundred molecules, which makes it difficult to distinguish genuine predictive value from statistical noise. The breadth of the ChEMBL antiviral collection also means the evaluation spans many viral targets and assay types rather than a single narrow endpoint, giving a more realistic picture of how the descriptors would perform in a working drug-discovery pipeline.

On the quantitative structure–property side, the study benchmarks the descriptors against twelve distinct QSPR endpoints, testing whether the product-connectivity family improves the prediction of physicochemical and related molecular properties. On the activity side, the authors tackle antiviral pEC50 prediction, where pEC50 is the negative base-10 logarithm of the half-maximal effective concentration, a standard measure of compound potency against viral targets. The modeling setup was deliberately controlled. For the QSPR tasks, the team used hold-out testing, reserving a portion of the data to evaluate models that had never seen it during training. For the QSAR task, they employed five-fold cross-validation, rotating the data so that every compound is tested exactly once. Both protocols are standard safeguards against overoptimistic performance estimates.

Equally important is the feature-block ablation design, which the authors describe as leakage-controlled. In descriptor studies, a common pitfall is information leakage, where features that implicitly encode the answer—such as experimental values or near-duplicate structures shared between training and test sets—inflate apparent accuracy. By organizing the feature space into blocks, including a block of RDKit descriptors, a block of physicochemical properties, and the new product-connectivity indices, and then systematically ablating, or removing, each block while controlling for leakage, the researchers could isolate the marginal contribution of the PCI family. This design directly addresses the question a skeptical reader would ask: do the new descriptors add anything beyond what established descriptor suites already capture?

The results, as reported in the study, show that the observed gains from the product-connectivity descriptors are dataset-dependent. The authors are explicit on this point, cautioning that the improvements should not be interpreted as universal superiority over richer descriptor spaces. This honesty is notable in a field where new descriptors are sometimes promoted with sweeping claims. What the study does establish is that the product-normalization strategy is a viable, theoretically grounded way to mitigate the dominance of highly connected substructures in additive degree-based indices, and that in appropriate datasets—particularly the antiviral QSAR setting that motivated the work—the family can measurably improve predictive performance within a fixed five-regressor modeling suite.

The choice to hold the regressor suite fixed across all experiments is itself methodologically meaningful. If the modeling algorithm changed between baseline and augmented feature sets, any performance difference could be attributed to the algorithm rather than the descriptors. By keeping five regressors constant and varying only the feature blocks, the authors ensure that observed differences trace back to the information content of the descriptors themselves. This controlled comparison, combined with the large curated dataset and the dual QSAR/QSPR evaluation, makes the study a useful template for how descriptor families should be validated going forward: theory first, then large-scale empirical benchmarking with leakage controls and ablations.

For the antiviral research community, the practical implications are straightforward. Antiviral drug discovery remains a pressing global need, and computational pre-screening that can reliably rank candidate compounds by predicted potency saves both time and laboratory resources. Degree-based topological indices are attractive precisely because they can be computed for millions of candidate molecules in seconds, and a normalization strategy that improves their signal quality without adding significant computational burden could sharpen the first filter through which candidate antivirals pass. The modular nature of the product-normalization approach means that practitioners can apply it to degree kernels they already use, rather than adopting an entirely new descriptor vocabulary.

The study also used only public chemical and bioactivity records and involved no human participants, human data, human tissue, animals, or animal tissue, and the article is published open access under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license, permitting non-commercial sharing and distribution with appropriate credit. As the field of machine-learning-guided drug discovery continues to expand, work of this kind—careful, theoretically grounded, and empirically honest about its limits—plays a quiet but essential role. New descriptors rarely make headlines on their own, but the cumulative effect of better-constructed, better-validated molecular representations is a more reliable computational foundation for the search for next-generation antiviral therapies.

Subject of Research: Product-connectivity topological descriptors for improving antiviral QSAR and QSPR prediction

Article Title: A theoretical and empirical evaluation of product connectivity descriptors for improving antiviral QSAR and QSPR prediction

Article References: A theoretical and empirical evaluation of product connectivity descriptors for improving antiviral QSAR and QSPR prediction. (n.d.). https://doi.org/10.1186/s12859-026-06654-2

Image Credits: AI Generated

DOI: 10.1186/s12859-026-06654-2

Keywords: topological indices, molecular descriptors, QSAR, QSPR, antiviral drug discovery, ChEMBL, chemoinformatics, machine learning, product connectivity, pEC50 prediction, BMC Bioinformatics, feature ablation